603 related articles for article (PubMed ID: 19125255)
1. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.
Neumann M; Kwong LK; Lee EB; Kremmer E; Flatley A; Xu Y; Forman MS; Troost D; Kretzschmar HA; Trojanowski JQ; Lee VM
Acta Neuropathol; 2009 Feb; 117(2):137-49. PubMed ID: 19125255
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
3. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
6. ALS and FTLD: two faces of TDP-43 proteinopathy.
Liscic RM; Grinberg LT; Zidar J; Gitcho MA; Cairns NJ
Eur J Neurol; 2008 Aug; 15(8):772-80. PubMed ID: 18684309
[TBL] [Abstract][Full Text] [Related]
7. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
Kwong LK; Neumann M; Sampathu DM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2007 Jul; 114(1):63-70. PubMed ID: 17492294
[TBL] [Abstract][Full Text] [Related]
10. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
[TBL] [Abstract][Full Text] [Related]
11. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies.
Robinson JL; Suh E; Xu Y; Hurtig HI; Elman L; McMillan CT; Irwin DJ; Porta S; Van Deerlin VM; Lee EB
Acta Neuropathol; 2024 Jun; 147(1):104. PubMed ID: 38896345
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
Braak H; Ludolph A; Thal DR; Del Tredici K
Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
[TBL] [Abstract][Full Text] [Related]
13. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
[TBL] [Abstract][Full Text] [Related]
14. Molecular neuropathology of TDP-43 proteinopathies.
Neumann M
Int J Mol Sci; 2009 Jan; 10(1):232-246. PubMed ID: 19333444
[TBL] [Abstract][Full Text] [Related]
15. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
Zhang YJ; Xu YF; Cook C; Gendron TF; Roettges P; Link CD; Lin WL; Tong J; Castanedes-Casey M; Ash P; Gass J; Rangachari V; Buratti E; Baralle F; Golde TE; Dickson DW; Petrucelli L
Proc Natl Acad Sci U S A; 2009 May; 106(18):7607-12. PubMed ID: 19383787
[TBL] [Abstract][Full Text] [Related]
16. Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins.
Kwong LK; Irwin DJ; Walker AK; Xu Y; Riddle DM; Trojanowski JQ; Lee VM
Acta Neuropathol Commun; 2014 Mar; 2():33. PubMed ID: 24690345
[TBL] [Abstract][Full Text] [Related]
17. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
18. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
[TBL] [Abstract][Full Text] [Related]
19. [Molecular dissection of TDP-43 in ALS and FTLD].
Hasegawa M; Arai T; Nonaka T; Tsuji H; Yamashita M; Hosokawa M; Kametani F; Tamaoka A; Akiyama H
Rinsho Shinkeigaku; 2010 Nov; 50(11):937-9. PubMed ID: 21921518
[TBL] [Abstract][Full Text] [Related]
20. [TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
Hasegawa M; Nonaka T; Yamashita M; Kametani F; Arai T; Yoshida M; Hashizume Y; Tsuchiya K; Akiyama H
Rinsho Shinkeigaku; 2009 Nov; 49(11):783-5. PubMed ID: 20030209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
